ePrints

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly (ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

Lookup NU author(s): Dr Yvette DrewORCiD, Dr Martin Highley, Julieann Sludden, Dr James Murray, Dr David Jamieson, Professor Alan Boddy, Professor Nicola CurtinORCiD, Professor Ruth Plummer

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Drew Y, Ledermann J, Hall G, Rea D, Glasspool R, Highley M, Jayson G, Sludden J, Murray J, Jamieson D, Halford S, Acton G, Backholer Z, Mangano R, Boddy A, Curtin N, Plummer R

Publication type: Article

Publication status: Published

Journal: British Journal of Cancer

Year: 2016

Volume: 114

Issue: 7

Pages: 723-730

Print publication date: 29/03/2016

Online publication date: 22/03/2016

Acceptance date: 25/01/2016

ISSN (print): 0007-0920

ISSN (electronic): 1532-1827

Publisher: Nature Publishing Group

URL: http://dx.doi.org/10.1038/bjc.2016.41

DOI: 10.1038/bjc.2016.41

PubMed id: 27002934

Altmetrics

Share